Agenus Inc AGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:31 PM EDT
12.58quote price arrow up+0.23 (+1.86%)
Volume
8,526
Close
12.35quote price arrow up+0.44 (+3.69%)
Volume
590,758
52 week range
4.78 - 42.60
Loading...
  • Open11.85
  • Day High13.10
  • Day Low11.53
  • Prev Close11.91
  • 52 Week High42.60
  • 52 Week High Date06/09/23
  • 52 Week Low4.78
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap259.341M
  • Shares Out21.00M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change-25.41

KEY STATS

  • Open11.85
  • Day High13.10
  • Day Low11.53
  • Prev Close11.91
  • 52 Week High42.60
  • 52 Week High Date06/09/23
  • 52 Week Low4.78
  • 52 Week Low Date04/18/24
  • Market Cap259.341M
  • Shares Out21.00M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change-25.41

RATIOS/PROFITABILITY

  • EPS (TTM)-12.68
  • P/E (TTM)-0.97
  • Fwd P/E (NTM)-1.52
  • EBITDA (TTM)-123.84M
  • ROE (TTM)-2,000.13%
  • Revenue (TTM)161.416M
  • Gross Margin (TTM)99.43%
  • Net Margin (TTM)-154.88%
  • Debt To Equity (MRQ)-6.74%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agenus Inc

 

Profile

MORE
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house...
Garo Armen Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Christine Klaskin
Vice President - Finance
Address
3 Forbes Rd
Lexington, MA
02421-7305
United States

Top Peers

SYMBOLLASTCHG%CHG
FGEN
FibroGen Inc
1.28+0.05+4.07%
XERS
Xeris Biopharma Holdings Inc
1.95-0.06-2.99%
STRO
Sutro Biopharma Inc
4.08-0.18-4.23%
AKBA
Akebia Therapeutics Inc
1.09-0.01-0.91%
KPTI
Karyopharm Therapeutics Inc
1.09-0.02-1.80%